Eyelid skin cancer: еpidemiology, prognosis
- Authors: Brovkina A.F.1, Lerner M.Y.2
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education at the Ministry of Health of Russia
- Branch № 1 “Ophthalmology Clinic” of the S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department
- Issue: Vol 7, No 1 (2017)
- Pages: 81-85
- Section: ORIGINAL REPORTS
- Published: 02.04.2017
- URL: https://ogsh.abvpress.ru/jour/article/view/240
- DOI: https://doi.org/10.17650/2222-1468-2017-7-1-81-85
- ID: 240
Cite item
Full Text
Abstract
Data on 3597 patients with primary malignant tumors of the visual organ were submitted to the Moscow City Cancer Register of the Moscow Healthcare Department in 2006–2015. Rate of eyelid skin cancer is 75.62 %. Calculated incidence is 3.4 per 100,000 population. The peak of the disease is at 70–80 years of age. The disease was diagnosed in people of age 46–85 years, it was 66.65 % more frequent in women than in men. Basal cell carcinoma comprised 91.14 % of all cases. In 65.7 % of cases the tumor was diagnosed at stage Т1 and Т2, and at stage Т1, when patient can be cured, only in 34 % of cases.
Objective. Study of incidence of malignant eyelid tumors of epithelial genesis, their prognostic characteristics using data from Moscow City Ophthalmic Oncology Center and Ophthalmic Oncology Department of the Branch # 1 “Ophthalmology Clinic” of the S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department.
About the authors
A. F. Brovkina
Russian Medical Academy of Continuous Professional Education at the Ministry of Health of Russia
Author for correspondence.
Email: anab@list.ru
2/1 Barrikadnaya St., Moscow, 125993, Russia Russian Federation
M. Yu. Lerner
Branch № 1 “Ophthalmology Clinic” of the S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department
Email: fake@neicon.ru
7 Mamonovskiy Lane, Moscow 123001, Russia Russian Federation
References
Supplementary files


